Sexual health

Female Sexual Dysfunction, Sorted Into Its Real Categories

Save

Told their problem is 'just stress' or 'just hormones,' many women never learn that sexual difficulties have real, named categories with real evaluations behind them. This is a map of the terrain — desire, arousal, orgasm, and pain — how clinicians tell them apart, and what the distress threshold and the FSFI actually mean.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is female sexual dysfunction?

Female sexual dysfunction is the clinical umbrella for persistent difficulty with sexual desire, arousal, orgasm, or pain that causes personal distress. Rather than a single diagnosis, it is a family of distinct problems, and professional guidance from ACOG organizes them so the right one can be identified and addressed 1. The umbrella exists because these problems overlap without being the same.

The distinction is practical, not academic. A woman whose desire has faded needs a different evaluation than one whose body will not become aroused despite wanting sex, or one who cannot reach orgasm, or one for whom sex hurts. Lumping them together as 'low libido' hides the very differences that determine what helps. female sexual dysfunction is not one problem but four — desire, arousal, orgasm, and pain.

The distress rule: what turns a difference into a disorder

A crucial threshold separates a variation from a disorder: personal distress. Hypoactive sexual desire disorder, for instance, is defined as a deficiency of sexual thoughts or desire lasting at least six months that causes the woman personal distress 2. Without that distress, low desire is a characteristic, not a diagnosis — and it needs no treatment.

This rule protects women from being medicalized against their own experience. Desire naturally varies across a life, a relationship, and a menstrual cycle, and a lower interest that does not trouble you is not something to fix. personal distress is the hinge the whole definition turns on: the question is never only whether something has changed, but whether the change bothers you. A screener or a clinic that skips that question is measuring the wrong thing. It also cuts the other way — real distress deserves to be taken seriously even when a partner or a previous clinician has waved it off as normal.

The four categories: desire, arousal, orgasm, and pain

Most female sexual concerns sort into four categories, and naming the right one turns a vague complaint into an answerable question. Desire is about wanting; arousal is about the body's physical response; orgasm is about release; and pain is its own category, not merely a symptom of the other three. Many women have more than one at once, and the categories feed each other — pain dampens desire, low desire blunts arousal — so untangling which came first is part of the work.

Desire. Low or absent interest in sex — the category that includes hypoactive sexual desire disorder (HSDD), the most common female sexual dysfunction 1. When a woman's sex drive disappears and the loss distresses her, this is the box it belongs in 2. Desire can be responsive rather than spontaneous, showing up once things are already pleasurable rather than arriving on its own, and a mismatch between what a woman expects and how desire actually works is sometimes the whole problem.

Arousal. The mind may be willing while the body does not follow — little lubrication, little physical response — even when desire is present. Arousal problems often overlap with the hormonal changes around menopause, and with the same blood-flow and nerve factors that shape sexual response more broadly.

Orgasm. Difficulty reaching orgasm, or a marked delay or reduction in it, despite adequate desire and arousal. When orgasm reliably will not come, anorgasmia in women is the specific term, and it can be lifelong or new — a distinction that matters, because a lifelong pattern and a recent change point in different directions.

Pain. Pain with attempted or completed intercourse. Clinicians now group persistent genital or pelvic pain and difficulty with penetration under a single diagnosis, genito-pelvic pain/penetration disorder, which folds together what used to be called dyspareunia and vaginismus 1. Pain is never 'in your head' by default, and it always deserves evaluation, because it usually has a physical, findable cause.

How common is female sexual dysfunction?

Common enough that most women will recognize themselves somewhere on this map at some point. Hypoactive sexual desire disorder is the most frequently reported female sexual dysfunction 1, and HSDD alone is estimated to affect roughly one in ten women 2. Sexual concerns are ordinary medical issues, not rare or shameful ones.

They are also not simply a consequence of aging or of being a woman. The male counterpart, erectile dysfunction, affects an estimated 30 to 50 million men in the United States and is likewise not an inevitable part of aging 3 — a reminder that sexual difficulties are treatable medical concerns across sexes, not private failings to be endured in silence. hypoactive sexual desire disorder affects roughly 1 in 10 women 2.

How it is evaluated — and where the FSFI fits

Evaluation starts with a conversation, not a test. A clinician takes a careful sexual and medical history, because the category, the timeline, and the distress together point toward the cause. Validated screeners support that history rather than replace it — for low desire, the Decreased Sexual Desire Screener is one such tool clinicians use to structure the assessment 2.

The instrument you are most likely to meet by name is the Female Sexual Function Index (FSFI). It is a questionnaire that measures sexual function across several domains — desire, arousal, lubrication, orgasm, satisfaction, and pain — and it is used in research and some clinics to put a structured number on an experience that is otherwise hard to describe. It is a way to organize the conversation and track change over time, not a self-diagnosis: a score does not by itself decide whether you have a disorder, and it does not replace the distress question or a clinician's judgment.

A thorough evaluation also looks for physical contributors — a pelvic exam when there is pain, a review of medications and medical conditions, and attention to hormonal changes — because the body and the story have to be read together. It is also the moment to catch problems that only look like a sexual complaint: a thyroid issue, depression, or a medication side effect can each present as low desire, and each has its own treatment. The instrument organizes the conversation; the exam and history are what turn it into an answer.

What causes it — usually more than one thing

Female sexual dysfunction rarely has a single cause. Biology, psychology, and relationship all feed into it, and a good evaluation looks across all three, because treating only one of them usually disappoints 1. That is why a thorough assessment asks about hormones and health, about mood and history, and about the relationship itself.

On the biological side, hormonal shifts — especially the drop in estrogen around menopause — can drive vaginal dryness and pain, and a number of medications affect desire and orgasm. Antidepressants are a frequent and under-discussed example; post-SSRI sexual dysfunction describes sexual effects that persist for some people even after the drug is stopped, and it is worth naming rather than brushing aside. On the psychological and relational side, stress, past experiences, mood disorders, body image, and the state of a partnership all shape desire and response. Because these layer, the fix is rarely a single pill, and the honest evaluation is the one that looks at the whole picture rather than reaching for the nearest prescription. That is also why two women with what looks like the 'same' low desire can need completely different help — one a change of medication, another treatment for a pain that was quietly killing interest, a third simply the room to talk honestly about a relationship.

Does female sexual dysfunction have treatment?

Yes, and the treatment follows the category — which is the whole reason sorting matters. There is no single fix, because a desire problem, a pain problem, and an arousal problem call for different responses, and ACOG's framework pairs the evaluation with management aimed at the specific diagnosis rather than a one-size answer 1. The honest headline is that most of these problems have real options, and the first step is naming which one you have.

Broadly, the approaches cluster by category. Pain is worked up for a physical cause — infection, skin conditions, pelvic-floor muscle problems, hormonal changes — and treated at the source, sometimes with pelvic-floor physical therapy. Arousal and dryness that track with menopause are often addressed by treating the tissue and hormonal changes directly. Desire concerns get a careful look at contributing factors — medications, mood, sleep, the relationship — because removing a cause often does more than adding a drug; where a specific treatment is appropriate, that is a discussion to have with a clinician. Counseling or sex therapy, alone or alongside medical treatment, helps across every category, because these problems rarely live in the body alone. A partner is often part of the treatment rather than a bystander, since desire and arousal respond to context, communication, and safety as much as to biology. This article names no specific medications or doses; the point is that options exist and are matched to the diagnosis, not handed out by default.

Bringing it to a clinician

The single most useful step is often the hardest: saying it out loud. Sexual concerns are legitimate medical topics, and a clinician who takes a sexual history is not embarrassed by the conversation — it is a routine part of care. Knowing which category fits, and that distress is what makes it a disorder, lets you walk in with a sharper question than 'something is wrong.'

It can help to prepare the way you would for any visit: when it started, whether it is about desire, arousal, orgasm, or pain, what else changed at the same time, and how much it bothers you. If you are unsure how to raise it, planning the sexual health conversation in advance makes it easier to get past the first sentence. From there the evaluation can do its job — and most of these problems have real, specific things that help. The worst outcome is also the most common one: a woman quietly decides the problem is simply who she is now, and never learns it had a name and a treatment all along.

Common questions

Low sexual desire — specifically hypoactive sexual desire disorder — is the most commonly reported form. It means persistently low interest in sex, lasting months, that causes personal distress. It is only one of four categories, though; arousal problems, difficulty with orgasm, and genital or pelvic pain each make up their own group, and many women experience more than one at the same time.

No. Desire naturally rises and falls across a life, a relationship, and a monthly cycle, and lower interest is only a disorder when it lasts and genuinely distresses you. A libido that has changed but does not bother you needs no treatment. That personal-distress threshold is deliberately built into the definition to keep normal variation from being medicalized.

The Female Sexual Function Index, or FSFI, is a questionnaire that measures sexual function across domains such as desire, arousal, lubrication, orgasm, satisfaction, and pain. Clinics and researchers use it to structure the conversation and track change over time. It is a tool to organize an assessment, not a self-diagnosis — a score does not by itself decide whether you have a disorder.

Yes. Several medications affect desire, arousal, or orgasm, and antidepressants are among the most common. For some people, sexual effects can even linger after stopping — a pattern described as post-SSRI sexual dysfunction. Hormonal changes, especially around menopause, also matter. This is exactly why an evaluation reviews your full medication list rather than assuming the problem is purely psychological.

Yes, and it is its own category. Persistent genital or pelvic pain and difficulty with penetration are grouped as genito-pelvic pain/penetration disorder, which combines what used to be called dyspareunia and vaginismus. Pain is not something to push through or explain away as being 'in your head' — it deserves a real evaluation, because it usually has a findable, treatable cause.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When sexual symptoms need prompt evaluation

  • New pelvic or genital pain along with fever, abnormal bleeding, or unusual discharge, which points to something beyond sexual function
  • Pain with sex that is new, severe, or steadily worsening, rather than long-standing
  • Sexual difficulty that arrives with numbness, weakness, or new bladder or bowel changes, which can signal a nerve problem

This article is general health education, not medical advice. Which category fits you, and what is driving it, can only be sorted out by a licensed clinician who can take a full history and examine you.

References

  1. 1.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology 134(1):e1-e18. PMID 31241595The ACOG framework for female sexual dysfunction — that it comprises distinct desire, arousal, orgasm, and pain problems, that hypoactive sexual desire disorder is the most common form, that persistent genital-pelvic pain and penetration difficulty are classified as genito-pelvic pain/penetration disorder, and that management is matched to the specific diagnosis.
  2. 2.Pettigrew JA, Novick AM (2021). An Overview of Hypoactive Sexual Desire Disorder: Physiology, Assessment, Diagnosis, and Treatment. Journal of Midwifery & Women's Health 66(6):740-748. doi:10.1111/jmwh.13283The definition of hypoactive sexual desire disorder (deficient sexual thoughts/desire for at least 6 months causing personal distress), its estimated prevalence of roughly 10% of women, and that diagnosis relies on clinical history and validated screeners such as the Decreased Sexual Desire Screener.
  3. 3.National Institute of Diabetes and Digestive and Kidney Diseases (NIH) (2017). Definition & Facts for Erectile Dysfunction. NIDDK (niddk.nih.gov). linkThat erectile dysfunction, the male counterpart, affects an estimated 30-50 million U.S. men and is not a normal or inevitable part of aging — used as a parallel that sexual dysfunction is a common, treatable medical concern rather than an inevitable part of aging.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy